Abstract
The association between myelodysplastic syndrome (MDS) and Behçet syndrome (BS) is recognized for over 25 years. High frequency of trisomy 8 and intestinal ulcers are striking features of this association. There are no recommendations for how these patients should be treated. A systematic literature review was performed in PubMed using the keyword combination “(((((intestinal) OR gastrointestinal) OR ulcer) OR Behcet*)) AND ((myelodysplastic syndrome) OR MDS)” in March 2019. Our aim was to gain insight regarding clinical responses to individual treatment modalities. A recent case was also presented and included in the analysis. Data from 41 articles reporting on a total of 53 patients carried adequate information to assess treatment responses. Glucocorticoids provided benefit in 23 of 43 patients. Azacitidine, decitabine, thalidomide, and cyclosporine contributed to a clinical improvement in 4/6, 2/3, 3/4, and 5/8 patients respectively. Hematopoietic stem cell transplantation was successful in 9 of 13 patients. With the use of TNF inhibitors, azathioprine, and mesalamine derivatives, clinical improvement was observed in 3/11, 0/4, and 6/18 patients respectively. Patients with MDS and BS-like features who are resistant to glucocorticoids have so far benefited more from treatment approaches directed at MDS, rather than the immunosuppressive agents used for BS.
Similar content being viewed by others
References
Ozguler Y, Hatemi G (2016) Management of Behçetʼs syndrome. Curr Opin Rheumatol [Internet] 28:45–50 [cited 2019 Apr 14] Available from: http://www.ncbi.nlm.nih.gov/pubmed/26555450
SM U (1996) Myelodysplastic syndromes. Semin Oncol Nurs [Internet] 12:51–58 Available from: http://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=107364735&lang=ja&site=ehost-live
Al UO, Ford LA, SJN S, AMW B, Barcos M, Vigil CE et al (2013) Myelodysplastic syndromes and autoimmune diseases—case series and review of literature. Leuk Res [Internet] 37:894–899 [cited 2019 Apr 3] Available from: https://linkinghub.elsevier.com/retrieve/pii/S0145212613001173
Sugimori C, List AF, Epling-Burnette PK (2010) Immune dysregulation in myelodysplastic syndrome. Hematol Rep [Internet] 2:1 Available from: http://www.pagepress.org/journals/index.php/hr/article/view/hr.2010.e1
Haga N, Iwata H, Yamaguchi Y, Shirato T, Nishimura K, Yamane N et al (2016) Mucocutaneous pyoderma gangrenosum due to trisomy 8 neutrophilic infiltrates in a patient with myelodysplastic syndrome. Br J Dermatol 174:239–241
Esatoglu SN, Hatemi G, Salihoglu A, Hatemi I, Soysal T, Celik AF (2015) A reappraisal of the association between Behçet’s disease, myelodysplastic syndrome and the presence of trisomy 8: a systematic literature review. Clin Exp Rheumatol 33:145–151
Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V (2017) Review one year in review. Behçet ’ s Syndr 2017:3–15
Seyahi E, Karaaslan H, Ugurlu S, Yazici H (2019) Fever in Behçet’s syndrome. Clin Exp Rheumatol [Internet] 31:64–67 [cited 2019 Mar 16] Available from: http://www.ncbi.nlm.nih.gov/pubmed/24064017
Cheon JH, Çelik AF, Kim WH (2010) Behçet’s disease: gastrointestinal involvement. In Behçet’s syndrome (pp. 165-188). Springer, New York. [cited 2018 Aug 9] Available from: http://link.springer.com/10.1007/978-1-4419-5641-5_10
Yazici H, Fresko I, Yurdakul S (2007) Behçet’s syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 3:148–155
Haase D (2008) Cytogenetic features in myelodysplastic syndromes. Anna Hematol 87(7):515–526
Wesner N, Drevon L, Guedon A, Fraison JB, Terrier B, Trad S et al (2018) Gastrointestinal Behcet’s-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature review. Leuk Lymphoma [Internet] 0:1–7. Taylor & Francis Available from:. https://doi.org/10.1080/10428194.2018.1542152
Wang S, Broder N, Marchetta P, Nowatzky J (2018) Myelodysplastic syndrome presenting as a Behçet’s-like disease with aortitis. BMJ Case Rep 2018:1–5
Lee S-S, Ahn J-S, Yun SJ, Park D-J (2017) Successful treatment of a patient with myelodysplastic syndrome accompanied by pyoderma gangrenosum and Behçet’s disease using allogeneic stem cell transplantation. Blood Res [Internet] 52:319–321 Korean Society of Hematology. [cited 2019 Aug 30]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29333411
Chen Y, Shen Y, Ma HF, Cai JF, Hua YQ, Zou J, Guan JL (2017) Infliximab associated with life-threatening lung infection in a patient with Behcet disease with intestinal and hematopoietic system involvement: a case report. Medicine 96(50):e9202
Matsumoto Y, Ota K, Yamada H (2019) Gastrointestinal: intestinal Behçet’s disease—like ulcers associated with myelodysplastic syndrome with monosomy 7. J Gastroenterol Hepatol 34:310
Nakamura Y, Matsuguma M, Tokunaga Y, Yamamoto K, Tanaka M, Tanaka Y et al (2017) Successful treatment of Behçet’s disease associated with acute myeloid leukemia with myelodysplasia-related changes using azacitidine and tacrolimus before allogeneic hematopoietic stem cell transplantation. Intern Med [Internet] 56:1199–1202 [cited 2018 Aug 8]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28502936
Kanamitsu K, Shimada A, Nishiuchi R, Shigemura T, Nakazawa Y, Koike K et al (2017) Pediatric intestinal Behçet disease complicated by myeloid malignancies. Int J Hematol Springer Japan 105:377–382
Yanai S, Nakamura S, Kawasaki K, Ito S, Sugai T, Matsumoto T (2016) Multiple colonic ulcers associated with trisomy 8: serial changes in colonoscopic findings. Clin J Gastroenterol Springer Japan 9:298–301
Ito K, Kubota K (2016) 18F-FDG PET/CT findings in 2 cases with myelodysplastic syndrome accompanied by Behçet’s disease. Clin Nucl Med 41:392–393
Kawano S, Hiraoka S, Okada H, Akita M, Iwamuro M, Yamamoto K (2015) Clinical features of intestinal Behçet’s disease associated with myelodysplastic syndrome and trisomy 8. Acta Med Okayama 69:365–369
Endo M, Sekikawa A, Tsumura T, Maruo T, Osaki Y (2015) A case of myelodysplastic syndrome with intestinal Behçet’s disease-like symptoms treated by prednisolone and azacitidine. Am J Case Rep 16:827–831
Lee WS, Kang MH, Hwang JH, Oh YJ, Yoo WH (2017) Allogeneic hematopoietic stem cell transplantation for refractory Behcet’s disease with myelodysplastic syndrome: a case report. Int J Rheum Dis 20(11):1860–1861
Kimura M, Tsuji Y, Iwai M, Inagaki M, Madian A, Yoshino T et al (2015) Usefulness of adalimumab for treating a case of intestinal Behçet’s disease with trisomy 8 myelodysplastic syndrome. Intest Res [Internet] 13:166 Available from: http://synapse.koreamed.org/DOIx.php?id=10.5217/ir.2015.13.2.166
Hu C, Lv L, Liu D, Huo J (2014) Treatment of Crohn’s disease complicated with myelodysplastic syndrome via allogeneic hematopoietic stem cell transplantation: case report and literature review. Clin J Gastroenterol 7:299–304
Takizawa Y, Setoguchi K, Kobayashi T, Kuwata G (2017) Severe gastrointestinal disease development coinciding with the progression of myelodysplastic syndrome after a long-term mild course of Behcet’s disease. Int J Rheum Dis 20:1856–1859
Kook M-H, Yhim H-Y, Lee N-R, Song E-K, Kim HS, Yim C-Y et al (2014) Successful treatment of myelodysplastic syndrome and Behcet colitis after allogeneic hematopoietic stem cell transplantation. Korean J Intern Med [Internet] 29:123–125 Available from: http://www.ncbi.nlm.nih.gov/pubmed/24574844%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC3932385
Soysal T, Saliho Lu A, Esato Lu SN, Gulturk E, AE EK, Hatemi G et al (2014) Bone marrow transplantation for Behcet’s disease: a case report and systematic review of the literature. Rheumatol Int 53:1136–1141 Available from: https://academic.oup.com/rheumatology/article-lookup/doi/10.1093/rheumatology/ket479
Handa T, Nakatsue T, Baba M, Takada T, Nakata K, Ishii H (2014) Clinical features of three cases with pulmonary alveolar proteinosis secondary to myelodysplastic syndrome developed during the course of Behçet’s disease. Respir Investig [Internet] 52:75–79. Elsevier. Available from:. https://doi.org/10.1016/j.resinv.2013.05.005
Toyonaga T, Nakase H, Matsuura M, Minami N, Yamada S, Honzawa Y et al (2013) Refractoriness of intestinal Behçet’s disease with myelodysplastic syndrome involving trisomy 8 to medical therapies -our case experience and review of the literature. Digestion 88:217–221
Koguchi-Yoshioka H, Inokuma D, Kanda M, Kondo M, Kikuchi K, Shimizu S (2014) Behçet’s disease-like symptoms associated with myelodysplastic syndrome with trisomy 8: a case report and review of the literature. Acta Derm Venereol 94:355–356
Tanaka H, Shimizu N, Tougasaki E, Kawajiri C, Hashimoto S, Takeda Y, Sakai S, Takeuchi M, Ohwada C, Sakaida E, Takagi T, Nakaseko C (2013) Successful treatment by azacitidine therapy of intestinal behçet’s disease associated with myelodysplastic syndrome. Int J Hematol 97:520–524
Fujimura T, Yukawa N, Nakashima R, Imura Y, Kawabata D, Nojima T, Ohmura K, Fujii T, Usui T, Mimori T (2010) Periodic fever and erythema nodosum associated with MDS with trisomy 8: report of two cases and review of the literature. Mod Rheumatol 20:413–419
Kovacs E, Nemeth H, Telek B, Ujfalusi A, Balogh E, Pasztor E, Pfliegler G (2009) Behçet’s disease in a patient with myelodysplastic syndrome. Clin Lymphoma Myeloma 9:459–461
Mantzourani MG, Chantziara K, Thanopoulou I, Variami H, Vaiopoulos G, Pangalis GA (2009) Coexistence of Behcet’s disease and chronic myelomonocyte leukemia with trisomy 8: a case report and review of the literature. Clin Exp Rheumatol 27:S85–S87
Nakamura F, Watanabe T, Hori K, Ohara Y, Yamashita K, Tsuji Y et al (2009) Simultaneous occurrence of inflammatory bowel disease and myelodysplastic syndrome due to chromosomal abnormalities in bone marrow cells. Digestion 79:215–219
Lin Y-C, Liang T-H, Chang H-N, Lin J-S, Lin H-Y (2008) Behçet disease associated with myelodysplastic syndrome. J Clin Rheumatol [Internet] 14:169–174 Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00124743-200806000-00010
Nonami A, Takenaka K, Sumida C, Aizawa K, Kamezaki K, Miyamoto T, Harada N, Nagafuji K, Teshima T, Harada M (2007) Successful treatment of myelodysplastic syndrome (MDS)-related intestinal Behcet’s disease by up-front cord blood transplantation. Intern Med 46:1753–1756
Kawabata H, Sawaki T, Kawanami T, Shimoyama K, Karasawa H, Fukushima T et al (2006) Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8. Intern Med [Internet] 45:1309–1314 Available from: http://joi.jlc.jst.go.jp/JST.JSTAGE/internalmedicine/45.1718?from=CrossRef
Thachil JV, Salim R, Field A, Moots R, Bolton-Maggs P (2008) Myelodysplastic syndrome with trisomy 8 associated with Behçet syndrome: an immunologic link to a karyotypic abnormality. Pediatr Blood Cancer [Internet] 50:649–651 [cited 2019 Jan 17]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17066465
Tomonari A, Tojo A, Takahashi T, Iseki T, Ooi J, Takahashi S, Nagamura F, Uchimaru K, Asano S (2004) Resolution of Behçet’s disease after HLA-mismatched unrelated cord blood transplantation for myelodysplastic syndrome. Ann Hematol 83:464–466
Ando S, Maemori M, Sakai H, Ando S, Shiraishi H, Sakai K et al (2005) Constitutional trisomy 8 mosaicism with myelodysplastic syndrome complicated by intestinal Behcet disease and antithrombin III deficiency. Cancer Genet Cytogenet 162:172–175
Kimura S, Kuroda J, Akaogi T, Hayashi H, Kobayashi Y, Kondo M (2001) Trisomy 8 involved in myelodysplastic syndromes as a risk factor for intestinal ulcers and thrombosis — Behçet’s syndrome. Leuk Lymphoma 42:115–121
Yano K, Eguchi K, Migita K, Takashima H, Tamura M, Izumino K, Sasagawa I, Sadamori N, Nagataki S (1996) Behcet’s disease complicated with myelodysplastic syndrome: a report of two cases and review of the literature. Clin Rheumatol 15:91–93
Della Rossa A, Tavoni A, Tognetti A, Testi C, Bombardieri S (1998) Behçet’s disease with gastrointestinal involvement associated with myelodysplasia in a patient with congenital panhypopituitarism. Clin Rheumatol [Internet] 17:515–517 Available from: http://www.ncbi.nlm.nih.gov/pubmed/9890682
Adachi Y, Tsutsumi A, Murata H, Takemura H, Chino Y, Takahashi R, Ebitsuka T, Sumida T (2003) Behçet’s disease accompanied by myelodysplastic syndrome with trisomy 8: two case reports and a review of 15 Japanese cases. Mod Rheumatol 13:90–94
Ogawa H, Kuroda T, Inada M, Yamamoto M, Enomoto H, Kishima Y, Yoshida K, Ito H, Ogawa H, Nakamura H (2001) Intestinal Behçet’s disease associated with myelodysplastic syndrome with chromosomal trisomy 8--a report of two cases and a review of the literature. Hepato-gastroenterology 48(38):416–420
Ishiguro A, Ishiguro Y, Uno Y, Yamagata K, Sakuraba H, Munakata A (2001) Colonic infiltration associated with myelodysplastic syndrome. Gastrointest Endosc 54:517–519
Fujita H, Kiriyama M, Kawamura T, Ii T, Takegawa S, Dohba S et al (2002) Massive hemorrhage in a patient with intestinal Behcet’s disease: report of a case. Surg Today [Internet] 32:378–382 Available from: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med4&NEWS=N&AN=12027208
Eder L, Rozenbaum M, Boulman N, Aayubkhanov E, Wolfovitz E, Zisman D, Rosner I (2005) Behçet’s disease, myelodysplastic syndrome, trisomy 8, gastroenterological involvement--an association. Clin Exp Rheumatol 23:S91–S95
Iwata S, Saito K, Yamaoka K, Tsujimura S, Nawata M, Hanami K, Tanaka Y (2011) Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet’s disease. Mod Rheumatol 21(2):184–191
Silverman LR, McKenzie DR, Peterson BL, Holland JF, Backstrom JT, Beach CL et al (2006) Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the cancer and leukemia group B. J Clin Oncol 24:3895–3903
Wesner N, Drevon L, Guedon A, Fraison JB, Trad S, Kahn JE et al (2019) Inflammatory disorders associated with trisomy 8-myelodysplastic syndromes: French retrospective case-control study. Eur J Haematol [Internet] 102:63–69 [cited 2019 Apr 2]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30218579
Goodyear OC, Dennis M, Jilani NY, Loke J, Siddique S, Ryan G, Nunnick J, Khanum R, Raghavan M, Cook M, Snowden JA, Griffiths M, Russell N, Yin J, Crawley C, Cook G, Vyas P, Moss P, Malladi R, Craddock CF (2012) Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML). Blood, The Journal of the American Society of Hematology 119(14):3361–3369
Frietsch JJ, Dornaus S, Neumann T, Scholl S, Schmidt V, Kunert C, Sayer HG, Hochhaus A, La Rosée P (2014) Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5‐azacytidine and literature review. Eur J Haematol 93(3):247–259
Sohlberg E, Pfefferle A, Andersson S, Baumann BC, Hellström-Lindberg E, Malmberg KJ (2015) Imprint of 5-azacytidine on the natural killer cell repertoire during systemic treatment for high-risk myelodysplastic syndrome. Oncotarget 6(33):34178
Arida A, Fragiadaki K, Giavri E, Sfikakis PP (2011) Anti-TNF agents for Behçet’s disease: analysis of published data on 369 patients. Semin Arthritis Rheum [Internet] 41:61–70. Elsevier Inc. Available from:. https://doi.org/10.1016/j.semarthrit.2010.09.002
Hatemi I, Esatoglu SN, Hatemi G, Erzin Y, Yazici H, Celik AF (2016) Characteristics, treatment, and long-term outcome of gastrointestinal involvement in Behcet’s syndrome a strobe-compliant observational study from a dedicated multidisciplinary center. Med (United States) 95:1–8
Acknowledgments
We would like to thank Dr. Jae-Yong Kwak for their kind response to our inquiry for the current health status of the patient they had reported in 2014.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
Informed consent was obtained for the use of the related medical records from the patient’s widow.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yilmaz, U., Ar, M.C., Esatoglu, S.N. et al. How to treat myelodysplastic syndrome with clinical features resembling Behçet syndrome: a case-based systematic review. Ann Hematol 99, 1193–1203 (2020). https://doi.org/10.1007/s00277-020-03951-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-020-03951-5